WHO updates its treatment guidelines to include molnupiravir
This ninth update of the World Health Organization’s (WHO) guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used ...
Staff ReporterMarch 7, 20222 min
This ninth update of the World Health Organization’s (WHO) guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used ...
Most people want to get more or better sleep. But besides just feeling refreshed when you wake up, working on your sleep habits can accomplish so much...
In the first year of the COVID-19 pandemic, global prevalence of anxiety and depression increased by a massive 25%, according to a scientific brief re...
The United States government, through the U.S. Agency for International Development (USAID) and the U.S. President’s Emergency Plan for AIDS Relief (P...
Over 1 billion people aged 12 to 35 years risk losing their hearing due to prolonged and excessive exposure to loud music and other recreational sound...
The Global Leaders Group on Antimicrobial Resistance today called on all countries to reduce the amount of antimicrobial waste entering the environmen...
“The artworks in the exhibit prove that heart disease remains to be a prevalent concern for Filipinos. We urge Congress to listen to these stories and...
The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalisation, says a ...
The World Health Organization (WHO) and the National Academy of Medicine (NAM) are encouraging social media companies and other digital platforms to a...